Arcutis Biotherapeutics (ARQT) insider trading in the last 6 months

Form 4 filings, newest first

Quality Score today 22

2 insiders sold $1.4M. No buys.

SellTerrie Curran$677KDirectorat $25.03 on Aug 27, filed Aug 28

SellTerrie CurranDirector$677Kat $25.03 on Aug 27, filed Aug 28

SellTerrie Curran$279KDirectorat $25.03 on Aug 27, filed Aug 28

SellTerrie CurranDirector$279Kat $25.03 on Aug 27, filed Aug 28

SellTerrie Curran$28KDirectorat $26.04 on Aug 20, filed Aug 24

SellTerrie CurranDirector$28Kat $26.04 on Aug 20, filed Aug 24

From SEC Form 4s, the newest filed Aug 28, 2026 · Insiders have 2 business days to file a trade

3 more filings on ARQT in the last 6 months, for Pro members. See them free →

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See all 6 tradesSee it live, free until Friday morning. No account. No card. Then keep going with a free account.

Pro members see every filing on ARQT with what each insider bought or sold and at what price, and can turn on an optional alert when an insider buys.

Who files at Arcutis Biotherapeutics

Terrie CurranDirector · 3 sales

Insider trades by person

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Questions about ARQT's insider trades

As of Nov 4, 2026: Arcutis Biotherapeutics (ARQT) has 6 insider filings on record in the last 6 months, the newest filed Aug 28, 2026. Its Quality Score is 22 (Exceptional). Scores as of 8:29 PM ET, 15 minutes behind.

Are ARQT insiders buying or selling?

2 insiders sold $1.4M across 6 filings in the last 6 months. No open-⁠market buys on record. The newest filing: Terrie Curran, Director, sold $677K on Aug 27, 2026.

Who are ARQT's biggest insider sellers?

By the dollars of their sales in the last 6 months: Terrie Curran (Director), 3 sales; Patrick Burnett (Insider), 3 sales.

When did an ARQT insider last buy?

No ARQT insider bought shares on the open market in the last 6 months, as filed on Form 4. The newest filing is a sale by Terrie Curran on Aug 27, 2026.

Arcutis Biotherapeutics's page has its Quality Score, its chart, and its earnings. More in Healthcare and Biotech.